Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: Therapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Brain Metastases [Phase 3]
A Phase 3 trial in non-squamous non-small cell lung cancer with brain metastases has been terminated; no results are provided in this update…
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial of GSK1572932A as adjuvant therapy in non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: A Global Study to Assess the Effects of MEDI4736 Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial assessing MEDI4736 (durvalumab) after concurrent chemoradiation in stage III unresectable non-small cell lung cancer has compl…
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Early Stereotactic Body Radiation Therapy to the Primary Tumor in Advanced Non-small Cell Lung Cancer [Phase 3]
This Phase 3 clinical trial update examines the efficacy of an epidermal growth factor receptor tyrosine kinase inhibitor used with early st…
-
CLINICAL_TRIALS trial_result · 2019-01-28Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of SH-1028 in Patients With Advanced NSCLC [Phase 1]
This Phase 1 trial update reports on the safety, tolerability, and pharmacokinetics of SH-1028 in patients with advanced non-small cell lung…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: The Efficacy and Drug Resistance Molecular Biology of Apatinib Combined With EGFR-TK1 Treated for Advanced Slow-progressed Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial evaluating the efficacy and resistance mechanisms of combining apatinib with an EGFR tyrosine kinase inhibitor for advanced sl…
-
CLINICAL_TRIALS trial_result · 2019-01-18Clinical Trial Update: A Study of Famitinib Plus Docetaxel in Patients With Advanced Non-squamous and Non-Small Cell Lung Cancer (NSCLC) [Phase 1]
A Phase 1 trial evaluating famitinib plus docetaxel in patients with advanced non-squamous non-small cell lung cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2019-01-18Clinical Trial Update: A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid Tumors [Phase 1]
A Phase 1 trial evaluating LY2584702 combined with erlotinib or everolimus in patients with solid tumors was terminated, and results have be…
-
CLINICAL_TRIALS trial_result · 2019-01-18Clinical Trial Update: SHR1020 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Squamous Non Small Cell Lung Cancer [Phase 3]
A Phase 3 trial evaluating SHR1020 plus docetaxel versus placebo plus docetaxel in second-line non-squamous non-small cell lung cancer has b…
-
CLINICAL_TRIALS trial_result · 2019-01-17Clinical Trial Update: Docetaxel and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Has Been Completely Removed By Surgery [Phase 2]
This Phase 2 trial evaluates adjuvant docetaxel and cisplatin in patients with stage I-III non-small cell lung cancer completely removed by …
-
CLINICAL_TRIALS trial_result · 2019-01-17Clinical Trial Update: LDK378 in Adult Chinese Patients With ALK-rearranged (ALK-positive) Advanced Non-small Cell Lung Cancer (NSCLC) Previously Treated With Crizotinib [Phase 1, Phase 2]
Phase 1/2 results for LDK378 (alectinib) in adult Chinese patients with ALK-rearranged advanced non-small cell lung cancer who were previous…
-
CLINICAL_TRIALS trial_result · 2019-01-17Clinical Trial Update: Efficacy and Safety of SCT200 in Patients With Advanced Squamous Non-small Cell Lung Cancer [Phase 1]
Phase 1 trial update evaluating the preliminary efficacy and safety of SCT200 in patients with advanced squamous non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2019-01-16Clinical Trial Update: Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer [Phase 4]
Phase 4 trial evaluating the combination of zoledronic acid and radiotherapy for bone metastases in non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2019-01-14Clinical Trial Update: Proton Radiotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 clinical trial update on proton radiotherapy for non-small cell lung cancer completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-01-11Clinical Trial Update: A Study of LDK378 in Patients With Non-small Cell Lung Cancer Harboring ROS1 Rearrangement [Phase 2]
A Phase 2 trial update for LDK378 in non-small cell lung cancer with ROS1 rearrangement is reported; the status is currently unknown.
-
CLINICAL_TRIALS trial_result · 2019-01-11Clinical Trial Update: A Phase III, Randomized, Multi-center Study to Determine the Efficacy of the Intercalating Combination Treatment of Chemotherapy and Gefitinib or Chemotherapy as Adjuvant Treatment in NSCLC With Common EGFR Mutations. [Phase 3]
Phase III randomized study assessing intercalating chemotherapy with gefitinib versus chemotherapy alone as adjuvant treatment in completely…
-
CLINICAL_TRIALS trial_result · 2019-01-11Clinical Trial Update: An Open-label, Multicenter, Phase II Study of LDK378 in Patients With Non-small Cell Lung Cancer Harboring ROS1 Rearrangement [Phase 2]
Phase II open-label study evaluating LDK378 in NSCLC patients with ROS1 rearrangement (phase 2).
-
CLINICAL_TRIALS trial_result · 2019-01-10Clinical Trial Update: Docetaxel Combined With Carboplatin Plus Anlotinib as First Line Treatment in NSCLC [Phase 4]
A Phase 4 clinical trial evaluating docetaxel plus carboplatin and anlotinib as first-line therapy for non-small cell lung cancer is ongoing…
-
CLINICAL_TRIALS trial_result · 2019-01-10Clinical Trial Update: Vitamin C and Tyrosine Kinase Inhibitor in Lung Cancer Patients With Epidermal Growth Factor Receptor Mutations [Phase 1, Phase 2]
A phase 1/2 clinical trial investigating the combination of Vitamin C with a Tyrosine Kinase Inhibitor in non-small cell lung cancer patient…
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: To Evaluate the Efficacy and Safety of SCT510 in the Treatment of Non-small Cell Lung Cancer [Phase 3]
A Phase 3 clinical trial update evaluating SCT510 for non-small cell lung cancer (non-squamous) is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: Trial of Ruxolitinib and Erlotinib in Patients With EGFR-mutant Lung Adenocarcinoma With Acquired Resistance to Erlotinib [Phase 1, Phase 2]
Phase 1/2 trial assessing the combination of ruxolitinib and erlotinib in EGFR-mutant lung adenocarcinoma with acquired resistance to erloti…
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating ibritinib in combination with MEDI4736 in relapsed/refractory solid tumors completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: 18F-FSPG PET/CT for Cancer Patients on Therapy [Phase 2]
Phase 2 clinical trial update on 18F-FSPG PET/CT for cancer patients undergoing therapy; study status completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Autologous Tcm Cells Immunotherapy in Patients With Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial update of autologous Tcm cell immunotherapy in patients with non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Study of Anlotinib in Advanced Non-squamous NSCLC Patients in the Elderly Without Systemic Chemotherapy (ALTER-L006) [Phase 4]
A Phase 4 clinical trial update evaluating anlotinib in elderly patients with advanced non-squamous non-small cell lung cancer who have not …